Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Index- P/E- EPS (ttm)-2.64 Insider Own1.16% Shs Outstand492.85M Perf Week-2.33%
Market Cap8.30B Forward P/E15.70 EPS next Y1.07 Insider Trans0.93% Shs Float488.46M Perf Month28.76%
Income-1302.00M PEG- EPS next Q0.24 Inst Own98.01% Short Float3.47% Perf Quarter3.26%
Sales4.37B P/S1.90 EPS this Y5.74% Inst Trans-3.01% Short Ratio3.94 Perf Half Y40.74%
Book/sh12.26 P/B1.37 EPS next Y13.61% ROA-8.74% Short Interest16.97M Perf Year99.88%
Cash/sh0.70 P/C24.05 EPS next 5Y8.93% ROE-19.24% 52W Range7.88 - 17.43 Perf YTD12.68%
Dividend Est.- P/FCF30.28 EPS past 5Y- ROI-11.05% 52W High-3.67% Beta1.43
Dividend TTM- Quick Ratio1.96 Sales past 5Y9.00% Gross Margin42.75% 52W Low113.07% ATR (14)0.57
Dividend Ex-Date- Current Ratio3.29 EPS Y/Y TTM-5619.91% Oper. Margin5.45% RSI (14)62.15 Volatility2.92% 3.51%
Employees9800 Debt/Eq0.95 Sales Y/Y TTM-1.91% Profit Margin-29.83% Recom2.07 Target Price19.09
Option/ShortYes / Yes LT Debt/Eq0.95 EPS Q/Q-69.14% Payout- Rel Volume0.71 Prev Close16.49
Sales Surprise1.45% EPS Surprise24.09% Sales Q/Q-4.14% EarningsMay 08 BMO Avg Volume4.31M Price16.79
SMA208.18% SMA5010.65% SMA20025.00% Trades Volume3,041,924 Change1.82%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Jul-21-22Downgrade Goldman Buy → Sell $32 → $19
Jul-12-22Initiated Piper Sandler Neutral $22
Nov-18-21Initiated Morgan Stanley Overweight $40
May-24-24 02:39AM
May-23-24 04:03PM
May-21-24 08:00AM
May-13-24 09:17AM
May-09-24 08:54PM
11:33AM Loading…
11:33AM
10:26AM
09:44AM
07:43AM
03:05AM
May-08-24 04:04PM
02:00PM
12:32PM
09:30AM
09:18AM
07:52AM Loading…
07:52AM
07:25AM
06:28AM
May-06-24 09:15AM
Apr-25-24 11:27AM
Apr-23-24 08:30AM
Apr-21-24 10:39AM
Apr-17-24 08:00AM
Apr-01-24 07:00AM
06:39AM
06:30AM
Mar-31-24 11:37PM
Mar-13-24 02:21PM
Mar-12-24 07:00PM
Mar-05-24 10:15AM
08:33AM Loading…
Mar-04-24 08:33AM
Feb-29-24 03:30PM
01:08PM
08:00AM
07:03AM
Feb-28-24 10:58AM
Feb-26-24 11:41PM
02:15PM
09:30AM
06:52AM
06:27AM
Feb-22-24 08:00AM
Feb-21-24 09:15AM
Feb-19-24 10:00AM
Feb-15-24 07:00AM
Feb-13-24 01:09PM
Feb-09-24 10:15AM
Feb-08-24 02:46PM
08:00AM
Feb-07-24 01:25PM
Feb-05-24 07:01AM
06:48AM
06:36AM
06:33AM
06:33AM
Jan-18-24 08:22PM
Jan-17-24 08:30AM
Jan-08-24 07:35AM
Jan-02-24 08:33AM
Jan-01-24 09:15AM
Dec-19-23 08:00AM
Dec-14-23 05:08PM
Dec-08-23 09:00AM
Dec-07-23 04:37PM
Nov-27-23 08:00AM
Nov-10-23 05:20PM
Nov-09-23 03:49AM
Nov-08-23 04:03PM
12:21AM
Nov-07-23 01:45PM
09:30AM
07:31AM
07:03AM
06:33AM
Nov-02-23 11:33AM
08:00AM
07:16AM
Nov-01-23 09:00AM
Oct-30-23 04:32PM
Oct-17-23 04:57PM
08:00AM
Oct-09-23 09:55AM
Oct-06-23 12:05PM
08:36AM
Oct-05-23 11:22AM
Oct-04-23 06:30AM
Sep-19-23 06:20AM
04:23AM
Sep-12-23 06:40AM
Sep-07-23 04:15PM
Sep-05-23 05:00PM
Aug-09-23 10:36AM
07:56AM
Aug-08-23 12:16AM
Aug-07-23 02:30PM
12:34PM
09:30AM
07:50AM
06:33AM
Aug-02-23 07:10AM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DOYLE WILLIAM FDirectorMay 21 '24Buy16.9815,000254,70076,330May 23 04:33 PM
DOYLE WILLIAM FDirectorMar 08 '24Buy16.3015,000244,50061,330Mar 12 04:32 PM
Harrington Michael JDirectorMar 08 '24Buy16.293,10050,49477,594Mar 12 04:30 PM
HOOVER R DAVIDDirectorMar 06 '24Buy16.1420,000322,808185,000Mar 08 05:09 PM
Last Close
May 24 04:00PM ET
23.15
Dollar change
+0.84
Percentage change
3.77
%
NVCR NovoCure Ltd daily Stock Chart
Index- P/E- EPS (ttm)-1.81 Insider Own9.96% Shs Outstand107.08M Perf Week5.28%
Market Cap2.49B Forward P/E- EPS next Y-1.76 Insider Trans-0.10% Shs Float96.89M Perf Month89.29%
Income-192.74M PEG- EPS next Q-0.41 Inst Own83.81% Short Float5.82% Perf Quarter55.37%
Sales525.66M P/S4.74 EPS this Y15.93% Inst Trans2.95% Short Ratio4.05 Perf Half Y94.21%
Book/sh3.34 P/B6.93 EPS next Y-7.26% ROA-16.79% Short Interest5.64M Perf Year-71.00%
Cash/sh8.12 P/C2.85 EPS next 5Y- ROE-48.70% 52W Range10.87 - 82.64 Perf YTD55.06%
Dividend Est.- P/FCF- EPS past 5Y-22.97% ROI-20.19% 52W High-71.99% Beta0.78
Dividend TTM- Quick Ratio5.99 Sales past 5Y17.16% Gross Margin74.97% 52W Low112.97% ATR (14)1.27
Dividend Ex-Date- Current Ratio6.26 EPS Y/Y TTM-34.69% Oper. Margin-39.07% RSI (14)71.94 Volatility7.45% 7.18%
Employees1453 Debt/Eq1.66 Sales Y/Y TTM0.61% Profit Margin-36.67% Recom2.14 Target Price25.50
Option/ShortYes / Yes LT Debt/Eq1.66 EPS Q/Q28.06% Payout- Rel Volume0.59 Prev Close22.31
Sales Surprise5.37% EPS Surprise14.29% Sales Q/Q13.36% EarningsMay 02 BMO Avg Volume1.39M Price23.15
SMA2030.27% SMA5051.86% SMA20044.32% Trades Volume815,769 Change3.77%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Neutral $15
Aug-28-23Downgrade H.C. Wainwright Buy → Neutral $85 → $25
Aug-08-23Upgrade Piper Sandler Neutral → Overweight $45
Aug-04-23Initiated SVB Securities Outperform $51
Jul-31-23Upgrade Evercore ISI Underperform → In-line $33
Jun-07-23Upgrade Wedbush Underperform → Neutral $53 → $46
May-16-23Upgrade Wells Fargo Equal Weight → Overweight $70 → $104
Mar-17-23Downgrade JP Morgan Neutral → Underweight $99 → $50
Jan-06-23Downgrade Wells Fargo Overweight → Equal Weight $89 → $107
Jan-05-23Reiterated H.C. Wainwright Buy $100 → $140
May-23-24 05:05PM
May-14-24 07:08AM
May-10-24 05:14PM
May-03-24 12:08PM
01:00AM
01:19PM Loading…
May-02-24 01:19PM
11:56AM
08:45AM
08:25AM
07:28AM
07:01AM
07:00AM
Apr-25-24 10:01AM
Apr-24-24 10:45AM
Apr-05-24 07:00AM
11:33AM Loading…
Apr-04-24 11:33AM
Apr-01-24 12:00PM
07:00AM
Mar-30-24 06:34AM
Mar-28-24 11:50AM
05:01AM
Mar-27-24 04:08PM
09:29AM
09:16AM
07:14AM
07:12AM
07:05AM
07:00AM
Mar-13-24 09:55AM
Mar-11-24 07:00AM
11:43AM Loading…
Feb-23-24 11:43AM
Feb-22-24 12:15PM
08:25AM
07:36AM
07:23AM
07:00AM
Jan-19-24 07:46AM
Jan-18-24 02:19PM
07:00AM
Jan-11-24 09:55AM
Jan-09-24 07:00AM
Jan-08-24 07:00AM
Jan-04-24 04:05PM
Dec-27-23 07:00AM
Dec-08-23 04:09AM
Dec-04-23 04:46PM
Nov-28-23 10:51AM
07:30AM
Nov-21-23 07:00AM
Nov-14-23 09:09AM
Nov-10-23 08:00AM
Nov-03-23 06:45AM
Oct-30-23 02:04AM
Oct-28-23 08:39AM
Oct-26-23 04:35PM
11:00AM
08:52AM
08:30AM
07:24AM
07:00AM
Oct-15-23 06:05PM
Oct-12-23 08:00AM
Oct-02-23 07:00AM
Sep-29-23 05:00PM
Sep-18-23 11:47AM
Sep-08-23 04:01PM
Sep-06-23 02:27PM
Sep-04-23 09:30AM
Aug-31-23 06:52PM
09:55AM
Aug-29-23 06:31PM
Aug-28-23 05:15PM
04:08PM
02:19PM
12:21PM
12:16PM
12:10PM
11:47AM
09:34AM
07:27AM
07:10AM
07:00AM
Aug-25-23 08:20AM
07:00AM
Aug-15-23 09:30AM
Aug-13-23 05:49PM
Aug-09-23 10:45AM
05:10AM
Aug-08-23 04:11PM
10:02AM
Aug-04-23 09:38AM
Aug-01-23 03:54PM
Jul-27-23 06:56PM
11:30AM
08:15AM
07:07AM
07:00AM
Jul-25-23 10:01AM
Jul-21-23 08:00AM
Jul-06-23 01:17PM
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GROENHUYSEN WILHELMUS CMChief Operating OfficerMar 04 '24Sale16.011,21719,484251,235Mar 05 04:09 PM
Leonard Frank XEVP, Pres., Novocure OncologyMar 04 '24Sale16.0184013,448160,098Mar 05 04:08 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerMar 01 '24Sale16.032,10733,769252,452Mar 05 04:09 PM
Leonard Frank XEVP, Pres., Novocure OncologyMar 01 '24Sale16.031,67926,909160,938Mar 05 04:08 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerFeb 28 '24Sale16.142,30337,177254,559Feb 29 04:28 PM
Leonard Frank XEVP, Pres., Novocure OncologyFeb 28 '24Sale16.142,07833,545162,617Feb 29 04:38 PM
Shah PriteshChief Growth OfficerNov 07 '23Sale12.653824,832124,511Nov 08 04:22 PM
Cordova AshleyChief Financial OfficerNov 02 '23Option Exercise11.461752,006117,618Nov 02 04:20 PM
Cordova AshleyChief Financial OfficerOct 31 '23Option Exercise9.5817,793170,447117,443Nov 02 04:20 PM
Cordova AshleyChief Financial OfficerSep 01 '23Sale21.8288319,26599,650Sep 05 04:24 PM
GROENHUYSEN WILHELMUS CMChief Operating OfficerSep 01 '23Sale21.822946,414209,825Sep 05 04:24 PM
Shah PriteshChief Growth OfficerSep 01 '23Sale21.822735,956124,893Sep 05 04:23 PM
Cordova AshleyChief Financial OfficerAug 02 '23Sale30.251,14434,607100,533Aug 04 04:02 PM